• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone.

作者信息

Bright G M, Rogol A D, Johanson A J, Blizzard R M

出版信息

Pediatrics. 1983 Apr;71(4):576-80.

PMID:6340044
Abstract

Two prepubertal males with low somatomedin-C concentrations in their sera, but normal growth hormone concentrations, had positive metabolic responses when human growth hormone was administered. An accelerated velocity of growth accompanied the long-term administration of growth hormone. This response was dependent upon the administration of exogenous hormone inasmuch as linear growth was subnormal both before and after administration of growth hormone. The extreme short stature in these individuals may be secondary to a biologically inactive growth hormone molecule that is immunologically reactive or to a decreased dose responsiveness of the cells that produce somatomedin when exposed to the usual concentrations of endogenous growth hormone.

摘要

相似文献

1
Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone.
Pediatrics. 1983 Apr;71(4):576-80.
2
Children with normal-variant short stature: treatment with human growth hormone for six months.正常变异型身材矮小儿童:使用人生长激素治疗六个月。
N Engl J Med. 1981 Jul 16;305(3):123-31. doi: 10.1056/NEJM198107163050302.
3
Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.采用免疫分析法对生长发育迟缓但生长激素水平正常的儿童进行人生长激素治疗:与生长调节素生成缺乏相关性。
Pediatrics. 1983 Mar;71(3):324-7.
4
The short child with subnormal plasma somatomedin C.血浆生长调节素C水平低于正常的矮小儿童。
Pediatr Res. 1985 Oct;19(10):975-80. doi: 10.1203/00006450-198510000-00001.
5
[Somatomedin activity and growth hormone secretion in children with idiopathic growth retardation (author's transl)].特发性生长迟缓患儿的生长调节素活性与生长激素分泌(作者译)
Arch Fr Pediatr. 1980 Oct;37(8):515-9.
6
The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.成骨不全症矮小儿童的生长激素和生长调节素轴
J Clin Endocrinol Metab. 1993 Jan;76(1):251-6. doi: 10.1210/jcem.76.1.8421094.
7
[Somatomedins].[生长调节素]
Wien Klin Wochenschr. 1987 May 1;99(9):306-12.
8
Growth and growth hormone. IV. Limitations of the growth hormone response to insulin and arginine and of the immunoreactive insulin response to arginine in the assessment of growth hormone deficiency in children.生长与生长激素。IV. 在评估儿童生长激素缺乏症时,生长激素对胰岛素和精氨酸反应的局限性以及免疫反应性胰岛素对精氨酸反应的局限性。
Pediatrics. 1969 Jun;43(6):989-1004.
9
[Radioimmunological determination of growth hormone following stimulation with insulin and arginine in 168 subjects with growth disorders].[对168例生长障碍患者经胰岛素和精氨酸刺激后生长激素的放射免疫测定]
Minerva Pediatr. 1976 May 12;28(17):1027-34.
10
Effects of human growth hormone administration on serum somatomedins, somatomedin carrier proteins, and growth rates in children with growth hormone deficiency.给予人生长激素对生长激素缺乏症儿童血清生长调节素、生长调节素载体蛋白及生长速率的影响。
J Clin Endocrinol Metab. 1982 Jul;55(1):49-55. doi: 10.1210/jcem-55-1-49.

引用本文的文献

1
Efficacy of long-term growth hormone therapy in short children with reduced growth hormone biological activity.长期生长激素治疗对生长激素生物活性降低的矮小儿童的疗效。
J Endocrinol Invest. 2011 May;34(5):366-9. doi: 10.1007/BF03347461. Epub 2011 Apr 20.
2
Genetics of isolated growth hormone deficiency.孤立性生长激素缺乏症的遗传学
J Clin Res Pediatr Endocrinol. 2010;2(2):52-62. doi: 10.4274/jcrpe.v2i2.52. Epub 2010 May 1.
3
Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on "Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time" by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625-38].
重组人生长激素-1治疗:黄金时机还是暂停?[对Bright GM、Mendoza JR、Rosenfeld RG所著《重组人生长激素-1治疗:准备进入黄金时期》的评论,发表于《北美内分泌与代谢临床》2009年;38:625 - 38]
Int J Pediatr Endocrinol. 2009;2009:429684. doi: 10.1155/2009/429684. Epub 2010 Feb 8.
4
Severe short stature and endogenous growth hormone resistance in twin brothers without growth hormone gene mutations.
Endocrine. 2003 Aug;21(3):289-95. doi: 10.1385/ENDO:21:3:289.
5
Molecular heterogeneity of human GH: from basic research to clinical implications.人生长激素的分子异质性:从基础研究到临床意义
J Endocrinol Invest. 2003 Mar;26(3):274-88. doi: 10.1007/BF03345170.
6
Biologically inactive growth hormone caused by an amino acid substitution.由氨基酸替代导致的无生物活性的生长激素。
J Clin Invest. 1997 Sep 1;100(5):1159-65. doi: 10.1172/JCI119627.
7
Effectiveness of growth hormone (GH) therapy in GH-deficient children and non-GH-deficient short children.
Eur J Pediatr. 1988 Apr;147(3):248-51. doi: 10.1007/BF00442689.